Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$2.45
-11.9%
$4.76
$2.27
$10.70
$94.07M1.32596,154 shs862,450 shs
National Research Co. stock logo
NRC
National Research
$33.69
-1.0%
$38.46
$32.08
$47.25
$811.77M0.4247,859 shs39,683 shs
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
$2.10
-4.5%
$2.31
$1.73
$3.79
$394.95M1.6410.83 million shs33.91 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
-11.73%+1.03%-36.98%-65.61%-61.07%
National Research Co. stock logo
NRC
National Research
-1.00%-1.55%-15.73%-15.65%-25.03%
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
0.00%0.00%0.00%0.00%-31.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
2.532 of 5 stars
3.41.00.00.01.71.72.5
National Research Co. stock logo
NRC
National Research
0.6104 of 5 stars
0.03.01.70.01.10.81.3
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
0.4949 of 5 stars
2.00.00.00.00.02.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
2.75
Moderate Buy$10.00309.00% Upside
National Research Co. stock logo
NRC
National Research
N/AN/AN/AN/A
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
2.00
Hold$2.4315.87% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$109.50M0.76$0.24 per share10.05$2.83 per share0.86
National Research Co. stock logo
NRC
National Research
$148.58M5.41$1.51 per share22.35$2.02 per share16.68
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
$97.67M4.04N/AN/A$3.00 per share0.70

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$9.28M-$0.08N/A9.40N/A-1.82%3.61%2.18%5/14/2024 (Estimated)
National Research Co. stock logo
NRC
National Research
$30.97M$1.2526.95N/A20.84%47.79%24.27%5/7/2024 (Confirmed)
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
-$109.16M-$0.69N/AN/AN/A-159.54%-24.72%-21.62%N/A

Latest LUNA, SLGC, and NRC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
National Research Co. stock logo
NRC
National Research
N/AN/AN/AN/AN/AN/A  
2/13/2024Q4 2023
National Research Co. stock logo
NRC
National Research
N/A$0.36+$0.36$0.36N/A$38.00 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/AN/AN/A
National Research Co. stock logo
NRC
National Research
$0.481.42%+31.73%38.40%N/A
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
N/AN/AN/AN/AN/A

Latest LUNA, SLGC, and NRC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2024
National Research Co. stock logo
NRC
National Research
Quarterly$0.121.2%3/27/20243/29/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.31
2.86
1.62
National Research Co. stock logo
NRC
National Research
0.60
0.67
0.67
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
N/A
17.79
17.29

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
87.46%
National Research Co. stock logo
NRC
National Research
47.26%
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
66.35%

Insider Ownership

CompanyInsider Ownership
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
7.60%
National Research Co. stock logo
NRC
National Research
2.00%
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
14.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
33733.96 million31.38 millionOptionable
National Research Co. stock logo
NRC
National Research
43523.85 million23.38 millionOptionable
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
451188.07 million160.05 millionOptionable

LUNA, SLGC, and NRC Headlines

SourceHeadline
Standard BioTools Inc LABStandard BioTools Inc LAB
morningstar.com - April 18 at 10:25 PM
LAB May 2024 2.500 callLAB May 2024 2.500 call
finance.yahoo.com - February 25 at 10:47 PM
Standard BioTools Inc.: Standard BioTools Stockholders Approve Merger with SomaLogicStandard BioTools Inc.: Standard BioTools Stockholders Approve Merger with SomaLogic
finanznachrichten.de - January 5 at 8:05 AM
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special MeetingMadryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting
finance.yahoo.com - January 4 at 8:10 PM
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioToolsMadryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
finance.yahoo.com - January 4 at 3:10 PM
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioToolsProxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
finance.yahoo.com - January 3 at 8:41 AM
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioToolsSomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools
finance.yahoo.com - January 2 at 9:39 AM
Boston Millennia Partners To Vote Against Proposed Merger Of SomaLogic With Standard BioToolsBoston Millennia Partners To Vote Against Proposed Merger Of SomaLogic With Standard BioTools
markets.businessinsider.com - January 1 at 8:18 AM
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioToolsLeading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioTools
finance.yahoo.com - December 29 at 7:20 PM
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional DisclosuresMadryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
finance.yahoo.com - December 29 at 7:20 PM
SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All StockholdersSomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders
finance.yahoo.com - December 29 at 9:18 AM
SomaLogic founder, CTO urge shareholders to vote against mergerSomaLogic founder, CTO urge shareholders to vote against merger
msn.com - December 28 at 7:15 PM
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogics Proposed Merger with Standard BioToolsDr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
finance.yahoo.com - December 28 at 7:15 PM
SomaLogic Issues Statement Correcting Madryn Asset Managements Misleading DisclosureSomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
finance.yahoo.com - December 26 at 6:51 PM
Another investor opposes Somalogic mergerAnother investor opposes Somalogic merger
bizwest.com - December 26 at 1:50 PM
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of AlternativesMadryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
finance.yahoo.com - December 26 at 1:50 PM
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsMadryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
businesswire.com - December 24 at 6:07 PM
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw "Cautionary Support" for SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsMadryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw "Cautionary Support" for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
finance.yahoo.com - December 24 at 1:07 PM
Tikvah Management Announces Intention to Vote against Somalogic’s Proposed Merger with Standard BioToolsTikvah Management Announces Intention to Vote against Somalogic’s Proposed Merger with Standard BioTools
finance.yahoo.com - December 22 at 8:41 PM
Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsMadryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
finance.yahoo.com - December 22 at 8:41 PM
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioToolsMadryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
finance.yahoo.com - December 22 at 9:48 AM
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor PresentationMadryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation
finance.yahoo.com - December 21 at 8:51 AM
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioToolsSomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
finance.yahoo.com - December 21 at 8:51 AM
MERGER INVESTIGATION: Kaskela Law LLC Announces Investigation of SomaLogic, Inc. (NASDAQ: SLGC)MERGER INVESTIGATION: Kaskela Law LLC Announces Investigation of SomaLogic, Inc. (NASDAQ: SLGC)
bakersfield.com - December 20 at 11:55 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Luna Innovations logo

Luna Innovations

NASDAQ:LUNA
Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.
National Research logo

National Research

NASDAQ:NRC
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Standard BioTools logo

Standard BioTools

NASDAQ:SLGC
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.